(Reprint from TECH.CO 8/9/2017) – Portland, Maine-based biotech company Abogen, founded in 2012, has developed a method and accompanying technology to extract blood cells from saliva, allowing for the potential replacement of up to 80 percent of the five billion invasive, needle-necessary blood samples drawn annually. The company is selling its product, but so far only for use in research and lab settings. Read more here.
